ICON Shares Outstanding 2006-2018 | ICLR

ICON shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ICON shares outstanding for the quarter ending September 30, 2018 were 0.055B, a 0.26% increase year-over-year.
  • ICON 2017 shares outstanding were 0.055B, a 2.76% decline from 2016.
  • ICON 2016 shares outstanding were 0.056B, a 6.44% decline from 2015.
  • ICON 2015 shares outstanding were 0.06B, a 4.5% decline from 2014.
ICON Annual Shares Outstanding
(Millions of Shares)
2017 55
2016 56
2015 60
2014 63
2013 62
2012 60
2011 61
2010 61
2009 60
2008 60
2007 59
2006 58
2005 0
ICON Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 55
Q2 2018 55
Q1 2018 55
Q4 2017 55
Q3 2017 55
Q2 2017 55
Q1 2017 55
Q4 2016 56
Q3 2016 57
Q2 2016 57
Q1 2016 56
Q4 2015 60
Q3 2015 60
Q2 2015 62
Q1 2015 62
Q4 2014 62
Q3 2014 63
Q2 2014 63
Q1 2014 63
Q4 2013 63
Q3 2013 62
Q2 2013 62
Q1 2013 61
Q4 2012 61
Q3 2012 60
Q2 2012 61
Q1 2012 61
Q4 2011 61
Q3 2011 61
Q2 2011 61
Q1 2011 61
Q4 2010 61
Q3 2010 61
Q2 2010 61
Q1 2010 60
Q4 2009 60
Q3 2009 60
Q2 2009 60
Q1 2009 60
Q4 2008 60
Q3 2008 62
Q2 2008 60
Q1 2008 60
Q4 2007 60
Q3 2007 60
Q2 2007 59
Q1 2007 59
Q4 2006 59
Q3 2006 58
Q2 2006 57
Q1 2006 0
Q4 2005 57
Q3 2005 57
Q2 2005 56
Q1 2005 56
Sector Industry Market Cap Revenue
Medical Medical Services $7.186B $1.758B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $55.055B 11.38
PRA Health Sciences (PRAH) United States $6.537B 26.68
Charles River Laboratories (CRL) United States $6.295B 22.07
HealthEquity (HQY) United States $5.293B 110.78
Premier (PINC) United States $5.276B 17.91
INC Research Holdings (SYNH) United States $5.161B 20.83
Teladoc (TDOC) United States $4.142B 0.00
NovoCure (NVCR) Jersey $2.933B 0.00
AMN Healthcare Services Inc (AMN) United States $2.890B 19.83
BioTelemetry (BEAT) United States $2.126B 37.55
Medpace Holdings (MEDP) United States $1.974B 24.42
Healthways (TVTY) United States $1.472B 18.10
Intrexon (XON) United States $1.393B 0.00
CareDx (CDNA) United States $1.165B 0.00
IKang Healthcare (KANG) China $1.161B 57.65
Natera (NTRA) United States $1.037B 0.00
China Cord Blood (CO) China $0.794B 21.07
Apollo Medical Holdings (AMEH) United States $0.742B 0.00
Surgery Partners (SGRY) United States $0.641B 0.00
Establishment Labs Holdings (ESTA) $0.536B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.34
Interpace Diagnostics (IDXG) United States $0.034B 0.00
Cancer Genetics (CGIX) United States $0.014B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00